Patients with insulin resistance, prediabetes, or type 2 diabetes often benefit most from GLP-1 or dual agonist therapies such as Wegovy, Ozempic, Mounjaro, or ZepBound
The TRIUMPH phase 3 trials, which concluded their primary endpoint in December 2025, demonstrated that Retatrutide could help patients lose nearly a third of their body weight
Follow-up visits are required to monitor your response to the medication and check for side effects
These powerful shots bypass the digestive system for immediate absorption, directly supporting nerve function and red blood cell production
Semaglutide was originally approved to help treat Type 2 diabetes
Factors GLP-1 Balance meals are ideal for anyone looking for support in maintaining progress on their GLP-1 journey